KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinomaNan Chen(Sun Yat-sen University), Li Zhang(Sun Yat-sen University)Cancer Immunology ImmunotherapyApril 27, 201710.1007/s00262-017-2005-zCited by 292SaveCiteExport RISWatch citationsRelated PapersExpression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer|Scientific Reports|2016|201PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival|Oncotarget|2015|93